Additionally, SE-lncRNAs such as TMEM44-AS1, CCAT1, LINC00152, and NEAT1 are identified as facilitators of glioma malignancy, reinforcing the prognostic and therapeutic potential of SE-lncRNA signatures [114]. The gene discussed is NEAT1; the disease is central nervous system cancer.